Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells

Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells

Abstract Background Ventral midbrain (VM) dopaminergic progenitor cells derived from human pluripotent stem cells have the potential to replace endogenously lost dopamine neurons and are currently in preclinical and clinical development for treatment of Parkinson’s Disease (PD). However, one main ch...

Full description

Bibliographic Details
Main Authors: Pedro Rifes, Marc Isaksson, Charlotte Rusimbi, Adrián Ramón Santonja, Jenny Nelander, Thomas Laurell, Agnete Kirkeby
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Stem Cell Research & Therapy
Subjects:
Mass spectrometry
Dopamine progenitors
ELISA
Quality control
Biomarkers
Cell replacement therapy
Online Access:https://doi.org/10.1186/s13287-023-03580-5

Internet

https://doi.org/10.1186/s13287-023-03580-5

Similar Items